Sun Pharmaceutical Industries Ltd.

SUNPHARMA

INE044A01036

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 05:19:40 12/02/2025 pm IST			5-day change	1st Jan Change
1,693.85 ^INR	-0.35%		-4.04%	-10.20%

04/02	Sun Pharmaceutical Industries Gets Tax Penalty Of 1.60 Bln Rupees	RE
04/02	India's JB Chem and Pharma meets Q3 profit view on steady domestic demand	RE

Nomura Adjusts Sun Pharmaceutical Industries' Price Target to INR1,970 From INR1,850, Keeps at Neutral

February 04, 2025 at 01:02 pm IST

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Gets Tax Penalty Of 1.60 Bln Rupees	04/02	RE
India's JB Chem and Pharma meets Q3 profit view on steady domestic demand	04/02	RE
Sun Pharmaceutical Industries Limited Receives an Order Passed by Addl. Commissioner of Central GST & Central Excise, Surat	04/02	CI
Sun Pharma Says Philogen Completes Patient Enrollment Of The Phase III Fibrosarc Trial In Soft Tissue Sarcoma	04/02	RE
Sun Pharmaceutical Industries Limited and Philogen Announces Successful Completion of Patient Enrollment in the Phase III FIBROSARC Trial for Soft Tissue Sarcoma	04/02	CI
Nomura Adjusts Sun Pharmaceutical Industries' Price Target to INR1,970 From INR1,850, Keeps at Neutral	04/02	MT
Sun Pharmaceutical Industries Limited Appoints Mr. Aalok Shanghvi as Chief Operating Officer	03/02	CI
Jefferies Adjusts Sun Pharmaceutical Industries' Price Target to INR2,265 From INR2,260, Keeps at Buy	03/02	MT
Sun Pharmaceutical Industries Limited, Q3 2025 Earnings Call, Jan 31, 2025	31/01
India's top drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales	31/01	RE
Sun Pharmaceutical Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	31/01	CI
Weight Loss Drug Semaglutide Launch in India to Mainly Benefit Larger Players, Jefferies Says	30/01	MT
Indian Markets Rebound on Tuesday as Financial Stocks Surge	28/01	MT
India's Mankind Pharma misses Q3 profit view as expenses jump	23/01	RE
Indian Markets Extend Gains as IT Stocks Shine on AI Optimism	23/01	MT
Sun Pharma Appoints Pulak Sarmah as Head of Corp Brand Marketing	15/01	CI
Gains in Auto, IT Stocks Push Indian Equities Higher on Tuesday	02/01	MT
Orexo, Sun Pharmaceutical Industries Settle Zubsolv Patent Dispute in US	16/12	MT
Sun Pharmaceutical Industries Limited Receives Order from Commissioner of Customs, Mumbai-III	13/12	CI
Exclusive-Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms	03/12	RE
Indian Equities Rebound on Friday, Aided by Heavyweights, Pharma Names	29/11	MT
Sun Pharmaceutical Industries Limited Receives Order from Regional Director, North Western Region, Ministry of Corporate Affairs	28/11	CI
Sun Pharmaceutical Industries Limited and Sun Pharma Laboratories Limited Receive Order from Office of the Commissioner of Customs,, Mumbai	26/11	CI
Indian Equities Tank on Tuesday as Investors Keep 'Sell on Rise' Strategy	12/11	MT
Sun Pharmaceutical Industries Limited Receives Order from Regional Director, North Western Region, Ministry of Corporate Affairs	06/11	CI

Chart Sun Pharmaceutical Industries Ltd.

Duration

Period

Chart Sun Pharmaceutical Industries Ltd.

SUNPHARMA: Dynamic Chart

Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).

Employees

43,000

Sector

Pharmaceuticals

Calendar

12/02/2025 - Nirmal Bang Institutional Equities Conference

More about the company